DoD Lupus, Impact Award

The Lupus Research Program Impact Award is a federal funding opportunity administered through the Defense Health Agency Contracting Activity under the Congressionally Directed Medical Research Programs. The program announcement supports high-risk and high-reward lupus research projects with the potential to create a significant impact on lupus science, treatment, patient outcomes, and quality of life. Congress initiated the Lupus Research Program in 2017 to fund innovative lupus research with exceptional scientific merit, and the fiscal year funding opportunity continues this mission through support for studies that address major unmet needs in lupus disease understanding and care. The program emphasizes transformative impact rather than incremental scientific advancement and specifically encourages applications from both established lupus investigators and researchers new to the lupus field who can contribute novel approaches and interdisciplinary methods. The funding opportunity focuses on several fiscal year focus areas that applicants must address. These include understanding lupus disease heterogeneity and its impact on disease progression and treatment response; investigating biological mechanisms of lupus disease; studying end organ injury and pathobiology; improving quality of life through social determinants of health, comparative effectiveness research, and health care access interventions; exploring genetic and epigenetic contributors to lupus; improving outcomes through innovative health care delivery models; and designing interventions to improve mental health and quality of life for individuals living with lupus. The program explicitly welcomes computational methodologies, systems biology, data science, epidemiological studies, personalized medicine approaches, maternal fetal health studies, and innovative health delivery technologies. Applications may focus on lupus patients of any age and may address populations with disproportionate health burdens. Approximately five awards are expected to be funded from an estimated total program allocation of five million dollars. Individual awards may request up to one million dollars in total costs across a maximum four-year period of performance. Indirect costs are allowable in accordance with negotiated institutional rates, and collaborating organizations may include their negotiated indirect rates within the overall project budget. The program does not require cost sharing or matching contributions from applicants. However, direct costs cannot be requested for clinical trial activities because clinical trials are specifically prohibited under this opportunity. The funding mechanism supports grants rather than contracts, and applications proposing classified research or research that could generate classified outcomes may be administratively withdrawn. Eligible applicants include domestic and international organizations, for-profit and nonprofit entities, public and private institutions, and intramural or extramural Department of War organizations. Independent investigators affiliated with eligible organizations may serve as Principal Investigators regardless of nationality or citizenship status. Individuals in mentored positions such as postdoctoral fellows or clinical fellows are not eligible to serve as Principal Investigators. Applicants are limited to one submission as Principal Investigator for this specific award mechanism during the fiscal year cycle. The program strongly encourages multidisciplinary collaborations involving academia, industry, military institutions, the Department of Veterans Affairs, and other federal agencies in order to leverage specialized populations, infrastructure, and data resources. The application process involves a mandatory two-step submission structure. Applicants must first submit a pre-application Letter of Intent through the Electronic Biomedical Research Application Portal. The Letter of Intent is limited to one page and must briefly describe the proposed research and identify the relevant focus area. Following successful pre-application submission, applicants may submit a full application either through Grants.gov for extramural organizations or through eBRAP for intramural Department of War organizations. Required application components include a Project Narrative, Supporting Documentation, Technical Abstract, Lay Abstract, Statement of Work, Impact Statement, Transition Plan, and additional supporting materials such as biosketches, budgets, and research sharing plans. Applications involving animal research require an Animal Research Plan, and clinical research applications may require inclusion enrollment documentation. Applicants must maintain active registrations in SAM.gov, Grants.gov, and eBRAP prior to submission. Applications undergo a two-tier review process consisting of peer review followed by programmatic review. Peer reviewers evaluate applications based on impact, research strategy and feasibility, personnel qualifications, and transition planning. Additional unscored considerations include budget appropriateness, research sharing plans, institutional environment, and overall presentation quality. Programmatic review then considers peer review results alongside portfolio composition, alignment with program priorities, and relative impact across the fiscal year program. Pre-applications are not formally screened or scored but are used for planning and reviewer recruitment purposes. Funding recommendations are typically communicated within approximately six weeks after programmatic review, and successful applicants may receive awards no later than September 30, 2027. Annual and final technical reports are required for funded projects, and all funded research involving animals or human subjects must receive additional regulatory approvals before implementation. Key dates for the current cycle include a pre-application deadline of July 29, 2026 and a full application deadline of August 19, 2026. The application verification period concludes on August 24, 2026. Peer review is anticipated during October 2026, followed by programmatic review in February 2027. Applicants are encouraged to begin registrations and application preparation early because there are no grace periods for late submissions. Technical support is available through the eBRAP Help Desk and the Grants.gov Support Center. The funding opportunity is identified by Funding Opportunity Number HT942526LRPIPA and is administered under Assistance Listing Number 12.420.

Emphasize high-risk high-reward impact rather than incremental advancement; clearly align the proposal to at least one FY26 focus area; demonstrate rigorous methodology and reproducibility standards; include strong rationale and feasible transition planning; explain significance to individuals living with lupus and military beneficiaries